Quick Takeaways
- Braeden Lichti filed SCHEDULE 13G/A for ENVERIC BIOSCIENCES, INC. Common Stock, $0.01 par value per share (ENVB).
- Disclosed ownership: 0%.
- Date of event: 09 Dec 2025.
Braeden Lichti - 09 Dec 2025 SCHEDULE 13G/A Report for ENVERIC BIOSCIENCES, INC. Common Stock, $0.01 par value per share (ENVB)
- Filing Manager
- Braeden Lichti
- Reporting Manager
- Braeden Lichti
- Symbol
- ENVB
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Dec 2025, 15:47:23 UTC
- Date of event
- 09 Dec 2025
- Previous filing
- 05 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Braeden Lichti disclosed 0% ownership in ENVERIC BIOSCIENCES, INC. Common Stock, $0.01 par value per share (ENVB) on 09 Dec 2025."
What Changed
- Previous schedule filing date: 05 Dec 2025.
- Current filing was accepted on 10 Dec 2025, 15:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Braeden Lichti | 0% | 0 | 0 | 0 | /s/ Braeden Lichti | Braeden Lichti | |
| Northstrive Fund II LP | 0% | 0 | 0 | 0 | /s/ Braeden Lichti | Braeden Lichti, Manager |